Literature DB >> 27062553

Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan.

Toshikazu Kubo1, Keiichiro Ueshima2, Masazumi Saito2, Masashi Ishida2, Yuji Arai2, Hiroyoshi Fujiwara2.   

Abstract

BACKGROUND: Steroid (glucocorticoid)-induced osteonecrosis of the femoral head (ONFH) in young adults has been a challenging disorder due to frequent incidence of collapse of the femoral head and resulting dysfunction of the hip joint and impairing quality of life. In Japan, the working group on ONFH in the Specific Disease Investigation Committee under auspices of the Japanese Ministry of Health, Labor and Welfare was founded in 1975, clinical and related basic research on ONFH have been continued for more than 40 years. EPIDEMIOLOGY AND CLINICAL COURSE: A national epidemiologic survey in 2004 estimated that 2200 new patients per year would be diagnosed with ONFH in Japan. ONFH was associated with steroid intake (51%), heavy alcohol intake (31%), both (3%), and neither (15%). The male-to-female ratio was 5:4, and the peak decades of age at definitive diagnosis were the 40s in male patients and the 30s in females. MRI studies revealed that ONFH would have occurred in early phase after start of steroid administration and no expansion of necrotic lesion within the femoral head in spite of continued steroid use. To standardize ONFH diagnosis and treatment strategy, the Committee established validated diagnostic criteria, a radiological staging system, and type categorization. TREATMENT OPTIONS: Most symptomatic patients with collapse of the femoral head require various surgical procedures. Joint preserving surgery, such as transtrochanteric rotational osteotomy and curved varus osteotomy, should be the treatment choice for young patients with healthy areas without severe collapse of the femoral head. CLINICAL AND RELATED BASIC RESEARCH: Clinical and basic research has been performed to determine the pathogenesis of steroid-induced ONFH. Low hepatic CYP3A activity has been reported to significantly contribute to the risk of steroid-induced ONFH. Several gene polymorphisms related to steroid metabolism were shown to be associated with the occurrence of ONFH.
Copyright © 2016 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27062553     DOI: 10.1016/j.jos.2016.03.008

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  44 in total

1.  Collagen type V a2 (COL5A2) is decreased in steroid-induced necrosis of the femoral head.

Authors:  Fan Yang; Pengbo Luo; Hao Ding; Changqing Zhang; Zhenhong Zhu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Circulating microRNA signature of steroid-induced osteonecrosis of the femoral head.

Authors:  Zheng Li; Chao Jiang; Xingye Li; William K K Wu; Xi Chen; Shibai Zhu; Chanhua Ye; Matthew T V Chan; Wenwei Qian
Journal:  Cell Prolif       Date:  2017-12-04       Impact factor: 6.831

Review 3.  Emerging roles of MicroRNAs in osteonecrosis of the femoral head.

Authors:  Zheng Li; Bo Yang; Xisheng Weng; Gary Tse; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2017-11-12       Impact factor: 6.831

4.  Association of reduced sclerostin expression with collapse process in patients with osteonecrosis of the femoral head.

Authors:  Xiao-Jun Chen; Fan Yang; Zhen-Qiu Chen; Min-Cong He; Guo-Ju Hong; Jun-Yuan Huang; Ying-Chun Zhou; Yi-Xian Qin; Qiu-Shi Wei; Wei He
Journal:  Int Orthop       Date:  2018-05-21       Impact factor: 3.075

5.  Neohesperidin promotes the proliferation and osteogenic differentiation of BMSCs via BMP2-Wnt/β-catenin pathway.

Authors:  Shuai Yuan; Chuanxin Zhang; Bo Wang
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

Review 6.  Association of Specific Genetic Polymorphisms with Atraumatic Osteonecrosis of the Femoral Head: A Narrative Review.

Authors:  Prasoon Kumar; Pratik M Rathod; Sameer Aggarwal; Sandeep Patel; Vishal Kumar; Karan Jindal
Journal:  Indian J Orthop       Date:  2022-01-06       Impact factor: 1.033

7.  GLUCOCORTICOID EXCESS IN BONE AND MUSCLE.

Authors:  Amy Y Sato; Munro Peacock; Teresita Bellido
Journal:  Clin Rev Bone Miner Metab       Date:  2018-02-05

8.  Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Isaac Guissou; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Hélène Rouard
Journal:  Int Orthop       Date:  2018-05-09       Impact factor: 3.075

9.  [Experimental study on improvement of osteonecrosis of femoral head with exosomes derived from miR-27a-overexpressing vascular endothelial cells].

Authors:  Gensheng Zhang; Ruiyu Liu; Xiaoqian Dang; Jichao Liu; Haibin Jiao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

10.  [Digital subtraction angiography assisted musculoskeletal flap transplantation for the treatment of osteonecrosis of the femoral head].

Authors:  Luqiao Pu; Yi Cui; Rongmao Shi; Bin He; Han Sun; Bo Wang; Yongqing Xu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.